Neoadjuvant adebrelimab in locally advanced resectable esophageal squamous cell carcinoma: a phase 1b trialJun Yin(Fudan University), Qing Zhou(BGI Group (China))Nature MedicineJuly 24, 202310.1038/s41591-023-02469-3Cited by 86SaveCiteExport RISWatch citationsRelated Papers<i>PADI4</i> rs2240337 G>A polymorphism is associated with susceptibility of esophageal squamous cell carcinoma in a Chinese population|Oncotarget|2017|4